Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. CDXC.NASDAQ

Chromadex Corp (CDXC NASDAQ) stock market data APIs

$3.19 0.12(3.9%) as of July 26, 2024
Price chart is built with Anychart

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Chromadex Corp Financial Data Overview

3.07
3.19
-
3.28
3.04
1.25-4.65
232 M
75 539 K
83 167 K
-0.01
1.874
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CDXC',
Type: 'Common Stock',
Name: 'Chromadex Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BG1J71',
ISIN: NULL,
CUSIP: NULL,
CIK: '1386570',
EmployerIdNumber: '26-2940963',
FiscalYearEnd: 'December',
IPODate: '2008-07-15',
InternationalDomestic: 'Domestic',
Sector: 'Consumer Defensive',
Industry: 'Packaged Foods',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Chromadex Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 83 167 K
  • EBITDA -3 387 000
  • Earnings Per Share -0.05
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Chromadex Corp Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -0.02

Get Chromadex Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Chromadex Corp latest news via APIs

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

LOS ANGELES, January 26, 2024--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, today announced that its Chi...

ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit

With the business potentially at an important milestone, we thought we'd take a closer look at ChromaDex Corporation's (NASDAQ:CDXC) future prospects. ChromaDex Corporation operates as a bioscience co...
Do you have any questions?
support@eodhistoricaldata.com